4.3 Article

PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Pathology

Mutation and Loss of Expression of ARID1A in Uterine Low-grade Endometrioid Carcinoma

Bin Guan et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)

Article Biochemistry & Molecular Biology

Clinicopathological Significance of Loss of ARID1A Immunoreactivity in Ovarian Clear Cell Carcinoma

Daichi Maeda et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)

Review Multidisciplinary Sciences

Chromatin remodelling during development

Lena Ho et al.

NATURE (2010)

Editorial Material Obstetrics & Gynecology

Researchers find a new cancer gene and a possible link between ovarian cancer and endometriosis

[Anonymous]

WOMENS HEALTH (2010)

Article Medicine, General & Internal

ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas

Kimberly C. Wiegand et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Pathology

Frequent Activating Mutations of PIK3CA in Ovarian Clear Cell Carcinoma

Kuan-Ting Kuo et al.

AMERICAN JOURNAL OF PATHOLOGY (2009)

Review Biochemistry & Molecular Biology

The SWI/SNF complex and cancer

D. Reisman et al.

ONCOGENE (2009)

Article Oncology

PIKK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia

Monica Prasad Hayes et al.

CLINICAL CANCER RESEARCH (2006)

Article Oncology

The prevalence of PIK3CA mutations in gastric and colon cancer

S Velho et al.

EUROPEAN JOURNAL OF CANCER (2005)

Article Biochemistry & Molecular Biology

PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas

JW Lee et al.

ONCOGENE (2005)

Article Multidisciplinary Sciences

Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic

SY Kang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

High frequency of mutations of the PIK3CA gene in human cancers

Y Samuels et al.

SCIENCE (2004)

Article Oncology

New guidelines to evaluate the response to treatment in solid tumors

F Duffaud et al.

BULLETIN DU CANCER (2000)

Article Oncology

New guidelines to evaluate the response to treatment in solid Tumors

P Therasse et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)